The Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP) has voted to recommend that pediatric patients (2 to 18 years old) who have not previously received hepatitis A vaccine be routinely vaccinated at any age.
Currently, the CDC recommends routine hepatitis A vaccination for children 12 to 23 months of age and catch-up vaccination for anyone over 2 years old who wishes to be vaccinated.
The new recommendation is being reviewed by the director of the CDC and the Department of Health and Human Services; the recommendation will become official once it is published in the CDC’s Morbidity and Mortality Weekly Report (MMWR).
Available hepatitis A vaccines include Havrix (GlaxoSmithKline) and Vaqta (Merck). Patients over the age of 18 may also receive Twinrix (GlaxoSmithKline), the combined hepatitis A and hepatitis B vaccine.